• Exchange: Berlin
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Cardiovascular Devices

Spectranetics Corp

+ Add to Watchlist


16.510 EUR 0.135 0.81%

As of 02:08:34 ET on 04/17/2014.

Snapshot for Spectranetics Corp (SC7)

Open: 16.526 Day's Range: 16.510 - 16.526 Volume: 0
Previous Close: 16.645 52wk Range: 11.650 - 22.800 1-Yr Rtn: +14.77%

Stock Chart for SC7

No chart data available.
  • SC7:GR 16.526
  • 1D
  • 1M
  • 1Y
Interactive SC7 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SC7

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.1570
Est. PEG Ratio -
Market Cap (M EUR) 682.34
Shares Outstanding (M) 41.33
30 Day Average Volume 71
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/23/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SC7

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SC7

The Spectranetics Corporation develops, manufactures, markets, and distributes its technology for interventional cardiovascular therapy. The Company's CVX-300 excimer laser system is used in applications such as coronary angioplasty and the removal of pacemaker leads. Spectranetics is also developing other applica- tions in restenosis stents and peripheral vascular applications.

Scott DrakePresident/CEOGuy A ChildsChief Financial Officer
Shahriar Matin "Shar"Senior VP:Ops & Bus DevKimberly BridgesSenior VP:Sales & Marketing
More Company Profile & Key Executives for SC7

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil